“Light-enhanced cytotoxicity & trafficking of the PD-L1-targeting photoimmunoconjugate EITC-atezolizumab” 👉 lnkd.in/dz-zF-Hx Novel: #Atezolizumab clusters w/ #CD63 pos #MVBs
#Photoimmunotherapy #lungcancer
#PDL1 #Tecentriq #NSCLC #PhotodynamicTherapy
“Light-enhanced cytotoxicity & trafficking of the PD-L1-targeting photoimmunoconjugate EITC-atezolizumab” 👉 lnkd.in/dz-zF-Hx Novel: #Atezolizumab clusters w/ #CD63 pos #MVBs
#Photoimmunotherapy #lungcancer
#PDL1 #Tecentriq #NSCLC #PhotodynamicTherapy
✨ PhD students Riccarda K Læret & Arno Bruel gave excellent talks!
✨ Inger Kristine F. Aukrust had a great poster presentation!
✨ Kristian Berg gave an inspiring Opening Lecture!
✨ Myself: New President of ESP🤗 🌞😎
#Photobiology & #PDT #ProudOfMyGroup
✨ PhD students Riccarda K Læret & Arno Bruel gave excellent talks!
✨ Inger Kristine F. Aukrust had a great poster presentation!
✨ Kristian Berg gave an inspiring Opening Lecture!
✨ Myself: New President of ESP🤗 🌞😎
#Photobiology & #PDT #ProudOfMyGroup
Dimitri Krysko, Lígia Catarina Gomes da Silva, Odrun Gederaas, Kaitlyn Moore, Arno Bruel, Brian Schnoor, Cristina Dias and Angeles Juarranz
Dimitri Krysko, Lígia Catarina Gomes da Silva, Odrun Gederaas, Kaitlyn Moore, Arno Bruel, Brian Schnoor, Cristina Dias and Angeles Juarranz
“Fortieth anniversary of the European Society of Photobiology. History and significance in the scientific community”.
“Fortieth anniversary of the European Society of Photobiology. History and significance in the scientific community”.
PPS has achieved Q1 status in the "Radiation" category and its 2024 impact factor has increased to 3.2.
Congratulations to everyone involved in this achievement: authors, reviewers, editors and journal staff!
PPS has achieved Q1 status in the "Radiation" category and its 2024 impact factor has increased to 3.2.
Congratulations to everyone involved in this achievement: authors, reviewers, editors and journal staff!
Thank you for your participation! We look very much forward to seeing you in Bari!
2/2
Thank you for your participation! We look very much forward to seeing you in Bari!
2/2